| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients
|
Isaacs, Claudine
|
|
2005
|
93 |
2 |
p. 125-134
|
artikel
|
| 2 |
Evidence for a Tumour Suppressive Function of APRG1 in Breast Cancer
|
Leris, A.C.A.
|
|
2005
|
93 |
2 |
p. 97-100
|
artikel
|
| 3 |
Incidence of Male Breast Cancer in California, 1988–2000: Racial/Ethnic Variation in 1759 Men
|
O’Malley, Cynthia
|
|
2005
|
93 |
2 |
p. 145-150
|
artikel
|
| 4 |
Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival
|
Ripple, Maureen O.
|
|
2005
|
93 |
2 |
p. 177-188
|
artikel
|
| 5 |
Innate Anti-breast Cancer Immunity of Apoptosis-resistant Human γδ-T cells
|
Guo, Ben L.
|
|
2005
|
93 |
2 |
p. 169-175
|
artikel
|
| 6 |
Multiple Signaling Pathways are Activated During Insulin-like Growth Factor-I (IGF-I) Stimulated Breast Cancer Cell Migration
|
Zhang, Xihong
|
|
2005
|
93 |
2 |
p. 159-168
|
artikel
|
| 7 |
Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?
|
Chaturvedi, Shailesh
|
|
2005
|
93 |
2 |
p. 151-158
|
artikel
|
| 8 |
RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast
|
Kleer, Celina G.
|
|
2005
|
93 |
2 |
p. 101-110
|
artikel
|
| 9 |
The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters
|
Gao, Rui-juan
|
|
2005
|
93 |
2 |
p. 111-115
|
artikel
|
| 10 |
The role of X-linked genes in breast cancer
|
Thakur, Archana
|
|
2005
|
93 |
2 |
p. 135-143
|
artikel
|
| 11 |
Timely Withdrawal of G-CSF Reduces the Occurrence of Thrombocytopenia During Dose-dense Chemotherapy
|
Timmer-Bonte, J.N.H.
|
|
2005
|
93 |
2 |
p. 117-123
|
artikel
|
Tijdschrift beschrijving